Colorectal cancer genetic heterogeneity delineated by multi-region sequencing

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Lu, You Wang ^a   Zhang, Hui Feng ^a,b   Liang, Rui ^b   Xie, Zhen Rong ^c   Luo, Hua You ^c,d   Zeng, Yu Jian ^c,d   Xu, Yu ^c,d   Wang, La Mei ^a   Kong, Xiang Yang ^a   Wang, Kun Hua ^a,c,d  

^a KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b First People's Hospital of Yunnan Province   (China)

^c KUNMING MEDICAL UNIVERSITY   (China)

^d Jie Shou Li Academician Workstation ^*  (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; GENOMIC DNA; K RAS PROTEIN; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PHOSPHOPROTEIN PHOSPHATASE 2; PROTEIN P53; RECEPTOR INTERACTING PROTEIN 140; SMAD4 PROTEIN;

ADULT; AGED; AR GENE; ARTICLE; CANCER GROWTH; CASE REPORT; CHINESE; COLON ADENOCARCINOMA; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; DATA ANALYSIS SOFTWARE; DISTANT METASTASIS; DNA SEQUENCE; FEMALE; GENETIC ANALYZER; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INDEL MUTATION; KMT2C GENE; LYMPH NODE METASTASIS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTATIONAL ANALYSIS; NCOR1 GENE; NEXT GENERATION SEQUENCING; ONCOGENE K RAS; PHYLOGENETIC TREE; PIK3CA GENE; POINT MUTATION; PPP2R1A GENE; PRIMARY TUMOR; SETD2 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SMAD4 GENE; SOMATIC MUTATION; SPLICING DEFECT; TUMOR BIOPSY; TUMOR GENE; TUMOR SUPPRESSOR GENE; COLORECTAL TUMOR; GENETICS; HIGH THROUGHPUT SEQUENCING; METASTASIS; PHYLOGENY; PROCEDURES;

AGED; COLORECTAL NEOPLASMS; FEMALE; GENETIC HETEROGENEITY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INDEL MUTATION; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PHYLOGENY; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 84962158391     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0152673     Document Type: Article

References (37)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: a cancer journal for clinicians. 2011;61(2):69-90. doi: 10.3322/caac.20107 PMID: 21296855.
2. Chen W, Zheng R, Zhang S, Zhao P, Li G, Wu L, et al. Report of incidence and mortality in China cancer registries, 2009. Chinese Journal of Cancer Research. 2013;25(1):10-21. doi: 10.3978/j.issn.1000-9604.2012.12.04 PMC3555299. PMID: 23372337
3. Siegel R, De Santis C, Jemal A. Colorectal cancer statistics, 2014. CA: a cancer journal for clinicians. 2014;64(2):104-17. doi: 10.3322/caac.21220
4. Kim TM, Jung SH, Baek IP, Lee SH, Choi YJ, Lee JY, et al. Regional biases in mutation screening due to intratumoural heterogeneity of prostate cancer. The Journal of pathology. 2014;233(4):425-35. doi: 10.1002/path.4380 PMID: 24870262.
5. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. The New England journal of medicine. 2012;366(10):883-92. Epub 2012/03/09. doi: 10.1056/NEJMoa1113205 PMID: 22397650.
6. Bolli N, Avet-Loiseau H, Wedge DC, Van Loo P, Alexandrov LB, Martincorena I, et al. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nature Communications. 2014;5. doi: 10.1038/ncomms3997
7. Zhang J, Fujimoto J, Zhang J, Wedge DC, Song X, Zhang J, et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science. 2014;346(6206):256-9. doi: 10.1126/science.1256930 PMID: 25301631; PubMed Central PMCID: PMC4354858.
8. Kim TM, Jung SH, An CH, Lee SH, Baek IP, Kim M, et al. Subclonal genomic architectures of primary and metastatic colorectal cancer based on intratumoral genetic heterogeneity. Clinical cancer research: an official journal of the American Association for Cancer Research. 2015. Epub 2015/05/17. doi: 10. 1158/1078-0432.ccr-14-2413 PMID: 25979483.
9. Kogita A, Yoshioka Y, Sakai K, Togashi Y, Sogabe S, Nakai T, et al. Inter- and intra-tumor profiling of multi-regional colon cancer and metastasis. Biochemical and biophysical research communications. 2015;458(1):52-6. doi: 10.1016/j.bbrc.2015.01.064 PMID: 25623536.
10. Berg KD, Glaser CL, Thompson RE, Hamilton SR, Griffin CA, Eshleman JR. Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction. The Journal of molecular diagnostics: JMD. 2000;2(1):20-8. Epub 2001/03/29. doi: 10.1016/s1525-1578 (10) 60611-3 PMID: 11272898; PubMed Central PMCID: PMC1906892.
11. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754-60. Epub 2009/05/20. doi: 10.1093/bioinformatics/btp324 PMID: 19451168; PubMed Central PMCID: PMC2705234.
12. De Pristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nature genetics. 2011;43(5):491-8. Epub 2011/04/12. doi: 10.1038/ng.806 PMID: 21478889; PubMed Central PMCID: PMC3083463.
13. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic acids research. 2010;38(16):e164. Epub 2010/07/06. doi: 10.1093/nar/gkq603 PMID: 20601685; PubMed Central PMCID: PMC2938201.
14. Sherry ST, Ward M-H, Kholodov M, Baker J, Phan L, Smigielski EM, et al. dbSNP: the NCBI database of genetic variation. Nucleic acids research. 2001;29(1):308-11. doi: 10.1093/nar/29.1.308 PMID: 11125122
15. Chen S, Zhou J, Zhang X, Zhou X, Zhu M, Zhang Y, et al. Mutation Analysis of the APC Gene in a Chinese FAP Pedigree with Unusual Phenotype. ISRN gastroenterology. 2011;2011:909121. doi: 10. 5402/2011/909121 PMID: 22164339; PubMed Central PMCID: PMC3226247.
16. Retief JD. Phylogenetic analysis using PHYLIP. Methods in molecular biology (Clifton, NJ). 2000;132:243-58. Epub 1999/11/05. PMID: 10547839.
17. Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013;502(7471):333-9. doi: 10.1038/nature12634 PMID: 24132290; PubMed Central PMCID: PMC3927368.
18. Alazzouzi H, Alhopuro P, Salovaara R, Sammalkorpi H, Jarvinen H, Mecklin JP, et al. SMAD4 as a prognostic marker in colorectal cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2005;11(7):2606-11. Epub 2005/04/09. doi: 10.1158/1078-0432. ccr-04-1458 PMID: 15814640.
19. Losi L, Bouzourene H, Benhattar J. Loss of Smad4 expression predicts liver metastasis in human colorectal cancer. Oncol Rep. 2007;17(5):1095-9. Epub 2007/03/29. PMID: 17390050.
20. Li X, Liu B, Xiao J, Yuan Y, Ma J, Zhang Y. Roles of VEGF-C and Smad4 in the lymphangiogenesis, lymphatic metastasis, and prognosis in colon cancer. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract. 2011;15(11):2001-10. doi: 10.1007/s11605-011-1627-2 PMID: 21786062.
21. Xiao D-S, Wen J-F, Li J-H, Wang K-S, Hu Z-L, Zhou J-H, et al. Effect of DPC4 Gene on Invasion and Metastasis of Colorectal Carcinoma Cells. Acta Biochimica et Biophysica Sinica. 2006;38(12):883-92. doi: 10.1111/j.1745-7270.2006.00233.x PMID: 17151782
22. Ma WL, Hsu CL, Yeh CC, Wu MH, Huang CK, Jeng LB, et al. Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis. Hepatology (Baltimore, Md). 2012;56(1):176-85. Epub 2012/02/10. doi: 10.1002/hep. 25644 PMID: 22318717; PubMed Central PMCID: PMC3673306.
23. Zhang BG, Du T, Zang MD, Chang Q, Fan ZY, Li JF, et al. Androgen receptor promotes gastric cancer cell migration and invasion via AKT-phosphorylation dependent upregulation of matrix metalloproteinase 9. Oncotarget. 2014;5(21):10584-95. Epub 2014/10/11. PMID: 25301736; PubMed Central PMCID: PMC4279395.
24. Kong D, Sethi S, Li Y, Chen W, Sakr WA, Heath E, et al. Androgen receptor splice variants contribute to prostate cancer aggressiveness through induction of EMT and expression of stem cell marker genes. The Prostate. 2015;75(2):161-74. Epub 2014/10/14. doi: 10.1002/pros.22901 PMID: 25307492; PubMed Central PMCID: PMC4270852.
25. Bluemn EG, Spencer ES, Mecham B, Gordon RR, Coleman I, Lewinshtein D, et al. PPP2R2C loss promotes castration-resistance and is associated with increased prostate cancer-specific mortality. Molecular cancer research: MCR. 2013;11(6):568-78. Epub 2013/03/16. doi: 10.1158/1541-7786. mcr-12-0710 PMID: 23493267; PubMed Central PMCID: PMC3687002.
26. Christianson DR, Dobroff AS, Proneth B, Zurita AJ, Salameh A, Dondossola E, et al. Ligand-directed targeting of lymphatic vessels uncovers mechanistic insights in melanoma metastasis. Proceedings of the National Academy of Sciences of the United States of America. 2015;112(8):2521-6. Epub 2015/02/11. doi: 10.1073/pnas.1424994112 PMID: 25659743; PubMed Central PMCID: PMC4345577.
27. McGranahan N, Swanton C. Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution. Cancer cell. 2015;27(1):15-26. doi: 10.1016/j.ccell.2014.12.001 PMID: 25584892
28. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759-67. doi: 10.1016/0092-8674 (90) 90186-I PMID: 2188735
29. Naxerova K, Brachtel E, Salk JJ, Seese AM, Power K, Abbasi B, et al. Hypermutable DNA chronicles the evolution of human colon cancer. Proceedings of the National Academy of Sciences of the United States of America. 2014;111(18):E1889-98. Epub 2014/04/23. doi: 10.1073/pnas.1400179111 PMID: 24753616; PubMed Central PMCID: PMC4020055.
30. Ruault M, Brun ME, Ventura M, Roizès G, De Sario A. MLL3, a new human member of the TRX/MLL gene family, maps to 7q36, a chromosome region frequently deleted in myeloid leukaemia. Gene. 2002;284(1-2):73-81. doi: 10.1016/S0378-1119 (02) 00392-X PMID: 11891048
31. Fujimoto A, Totoki Y, Abe T, Boroevich KA, Hosoda F, Nguyen HH, et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nature genetics. 2012;44(7):760-4. http://www.nature.com/ng/journal/v44/n7/abs/ng.2291. html. doi: 10.1038/ng.2291 PMID: 22634756
32. Pickering CR, Zhou JH, Lee JJ, Drummond JA, Peng SA, Saade RE, et al. Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clinical cancer research: an official journal of the American Association for Cancer Research. 2014;20(24):6582-92. doi: 10.1158/1078-0432. CCR-14-1768 PMID: 25303977; PubMed Central PMCID: PMC4367811.
33. Song Y, Li L, Ou Y, Gao Z, Li E, Li X, et al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature. 2014;509(7498):91-5. doi: 10.1038/nature13176 PMID: 24670651
34. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature. 1995;377(6548):397-404. PMID: 7566114
35. Merrell KW, Crofts JD, Smith RL, Sin JH, Kmetzsch KE, Merrell A, et al. Differential recruitment of nuclear receptor coregulators in ligand-dependent transcriptional repression by estrogen receptoralpha. Oncogene. 2011;30(13):1608-14. Epub 2010/11/26. doi: 10.1038/onc.2010.528 PMID: 21102521.
36. Cancer Genome Atlas N. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330-7. doi: 10.1038/nature11252 PMID: 22810696; PubMed Central PMCID: PMC3401966.
37. Brannon AR, Vakiani E, Sylvester BE, Scott SN, McDermott G, Shah RH, et al. Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions. Genome biology. 2014;15(8):454. Epub 2014/08/29. doi: 10.1186/s13059-014-0454-7 PMID: 25164765; PubMed Central PMCID: PMC4189196.